|
Volumn 145, Issue 1, 2001, Pages 75-78
|
Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: A phase I/II study
|
Author keywords
Basal cell carcinoma; Meta tetrahydroxyphenylchlorin; Photodynamic therapy
|
Indexed keywords
PHOTOSENSITIZING AGENT;
TEMOPORFIN;
ARTICLE;
BASAL CELL CARCINOMA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
EDEMA;
ERYTHEMA;
HEALING;
HUMAN;
HUMAN TISSUE;
ILLUMINATION;
LIGHT;
PARAMETER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHOTODYNAMIC THERAPY;
PHOTOTOXICITY;
PRIORITY JOURNAL;
TISSUE REACTION;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CARCINOMA, BASAL CELL;
FOLLOW-UP STUDIES;
HUMANS;
MESOPORPHYRINS;
PHOTOCHEMOTHERAPY;
PHOTOSENSITIZING AGENTS;
PROSPECTIVE STUDIES;
RADIATION DOSAGE;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 0034832389
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.2001.04284.x Document Type: Article |
Times cited : (58)
|
References (10)
|